The Medication-Assisted Therapy (MAT) Expansion Project seeks to expand access to medication-assisted treatment (MAT) for persons with opioid use disorder (OUD) in rural Oklahoma; with the hope of reducing opioid use, emergency department visits, and overdose deaths.

We are working with primary care providers in rural counties in Northeast, Southeast, North Central, and South Central Oklahoma to expand MAT for persons with OUD. This project is being funded by the Agency for Healthcare Research and Quality (AHRQ) in response to the opioid epidemic. Oklahoma is one of five states receiving this funding from AHRQ. The program offers practical, hands-on assistance to you and your office team through training, case-based consultations with addiction specialists, and mentoring from experienced MAT providers.This project includes an evaluation component to help determine the effectiveness of expanding rural access to MAT through provider training and mentoring. Practices will receive a stipend to facilitate data collection.

If you'd like to listen to a recording of our informational webinar, entitled "Medication-Assisted Treatment in Rural Oklahoma," please follow this link.

Who is eligible to participate?

  • Internists, family medicine physicians, doctors of osteopathic medicine, physician assistants, and nurse practitioners who provide primary care services in an office-based setting.

  • Participating practices must be located in the following Oklahoma counties:

    • Northeastern and Southeastern: Adair, Atoka, Bryan, Cherokee, Choctaw, Craig, Delaware, Latimer, LeFlore, Mayes, McCurtain, Muskogee, Nowata, Okmulgee, Ottawa, Pittsburg, Pushmataha, Sequoyah or Washington.

    • North Central and South Central: Blaine, Carter, Coal, Garfield, Garvin, Grant, Hughes, Jefferson, Johnston, Kay, Kingfisher, Logan, Love, Marshall, Murray, Noble, Okfuskee, Pawnee, Payne, Pontotoc, Pottawatomie, Seminole, or Stephens.

  • Primary Care Providers, including Nurse Practitioners and Physician Assistants, should either currently hold or desire to obtain a Drug Addiction Treatment Act of 2000 (DATA 2000) or Comprehensive Addiction and Recovery Act of 2016 (CARA 2016) authorized waiver to dispense or prescribe Schedule III, IV, and V narcotic medications approved by the FDA (e.g., buprenorphine) for the treatment of OUD in an office-based setting.

What are the benefits to participating practices?

    • Participants will receive education to enable them to obtain a DATA 2000 or CARA 2016 authorized waiver for prescribing buprenorphine in office-based settings, and to effectively support patients affected by, or at risk of, OUD.

              • For Physicians, more information about obtaining a SAMHSA waiver can be found here.

              • For NPs and PAs, more information about obtaining a SAMHSA waiver can be found here.

              Primary Care Providers  and their staff will receive practical, case-based teaching and mentorship on treating patients with OUD, and guidance on incorporating MAT into the practice. The project offers both access to local MAT experts and remote ECHO-model (

http://echo.unm.edu/) video consultations with peers and addiction specialists (webcams and software are provided).

  • Primary Care Providers can earn continuing medical education (CME) credits for attending training, with an option to fulfill the requirements of the new American Society of Addiction Medicine (ASAM) Fundamentals of Addiction Medicine 40-Hour Program. (http://www.asam.org/education/live-online-cme/fundamentals-of-addiction-medicine/fundamentals-program)

  • Your participation in the MAT Expansion Project will help expand access to needed treatment for rural Oklahomans experiencing OUD, and will help develop best practices for rural primary care providers nationwide who want to implement MAT.

What training opportunities and support are provided?

Our team offers extensive experience in OUD treatment, provider education and trainings, and consultation. We make available at no cost to you:

  • Online and in-person trainings in the fundamentals of addiction medicine

  • Case-based learning via remote consultative clinics (i.e., ECHO-model learning and mentoring sessions)

  • Support for coordinating care with behavioral health and community services

  • Access to tailored consultations with local primary care colleagues who have successfully implemented MAT services in their practices

  • A stipend to facilitate data collection for a planned evaluation of the MAT training and support program.

When is the program being offered?

Training and expert support will be offered in two cohorts:

    • Wave 1:   August 2017 to September 2019. *WAVE 1 Is Underway*

    • Wave 2 :  January 2018 to September 2019. *WAVE 2 Is Underway* 

Want to learn more about the project? Sign up for an informational webinar with the project team and our consulting physicians.